KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Gross Margin (2019 - 2025)

GoodRx Holdings' Gross Margin history spans 7 years, with the latest figure at 163.57% for Q4 2025.

  • For Q4 2025, Gross Margin rose 11082.0% year-over-year to 163.57%; the TTM value through Dec 2025 reached 92.77%, up 2924.0%, while the annual FY2025 figure was 92.77%, 3911.0% up from the prior year.
  • Gross Margin for Q4 2025 was 163.57% at GoodRx Holdings, up from 57.39% in the prior quarter.
  • Across five years, Gross Margin topped out at 174.51% in Q3 2022 and bottomed at 24.14% in Q3 2021.
  • The 5-year median for Gross Margin is 74.87% (2022), against an average of 75.14%.
  • The largest annual shift saw Gross Margin plummeted -14802bps in 2021 before it surged 19865bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 50.06% in 2021, then surged by 81bps to 90.57% in 2022, then grew by 2bps to 92.29% in 2023, then plummeted by -43bps to 52.75% in 2024, then soared by 210bps to 163.57% in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Gross Margin are 163.57% (Q4 2025), 57.39% (Q3 2025), and 93.43% (Q2 2025).